Top Story

Migraine–CAD link may not have genetic basis

July 6, 2015

Previous research established an association between CAD and migraine, especially migraine with aura, but new study data suggest that gene variants may not be the cause. In fact, genetic variants shared by migraine without aura and CAD were protective against CVD, researchers reported.

“Surprisingly, when we looked for shared gene variants that might help explain part of the link between migraine and heart disease, we found no shared gene variations between migraine with aura and heart disease,” Aarno Palotie, MD, from Massachusetts General Hospital and the Broad Institute of the Massachusetts Institute of Technology and Harvard University, said in a press release. “This is surprising because the evidence is stronger that people with migraine with aura have an increased risk of heart disease than people with migraine without aura.”

PCSK9 inhibitors: What you should know

July 5, 2015
Proprotein convertase subtilisin/kexin type 9, also known as PCSK9, provides instructions for the body to produce a protein that helps regulate the amount of cholesterol…

ACC launches Statin Intolerance App

July 4, 2015
The American College of Cardiology has launched a free app designed to aid clinicians in the management and treatment of patients who report adverse muscular symptoms…
FDA News

FDA clears scoring balloon catheters with larger diameter

July 3, 2015
Spectranetics recently announced that it has received FDA 510(k) clearance for a scoring balloon catheter in diameters of 7 mm and 8 mm to treat a narrowed fistula…
In the Journals

Physician urges FDA not to lift restrictions on drug makers’ claims about their products

July 3, 2015
Drug regulations and a governing body to mandate them is a necessity for patients’ safety and health care providers’ peace-of-mind, according to a recently…
More News Headlines »
Antiplatelet Therapy in ACS and PCI

Antiplatelet Therapy in ACS and PCI

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC.

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »
Meeting News Coverage Video
VIDEO: Knowledge of supplements and drug interactions essential for HF practitioners

VIDEO: Knowledge of supplements and drug interactions essential for HF practitioners

June 28, 2015
NEW ORLEANS – Joseph Ho, PharmD, clinical pharmacist with Ochsner Baptist Medical Center in New Orleans…
More »
CME
Oral Antiplatelet Therapy in a Patient with Acute Coronary Syndrome and Percutaneous Coronary Intervention

Case Study: Oral Antiplatelet Therapy in a Patient with ACS and PCI

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

It is estimated that in the United States, over 780,000 persons annually will experience an acute coronary syndrome…
More »
morganatic-roan
morganatic-roan